Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Implementation of Precision Medicine in High-risk Prostate Cancer
A ClinicalTrials.gov entry describes a study on implementing precision medicine in high-risk prostate cancer, currently recruiting participa…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Long Acting Neuraxial Peri-prostatic Block in Cancer [Phase 1]
Phase 1 clinical trial update for a long-acting neuraxial peri-prostatic block in cancer targeting prostate cancer; the trial is currently a…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRI
A completed clinical trial evaluating adaptive radiotherapy for high-risk prostate cancer guided by multiparametric MRI to personalize treat…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HRS-1167 tablets in combination with abiraterone acetate and prednisone for metastatic prostate cancer…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI [NA]
A completed clinical trial update evaluating detection of post-radiation local recurrences of prostate cancer using Histoscanning and MRI.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating stereotactic focal radiotherapy as an alternative to active surveillance for low- …
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors [NA]
A completed clinical trial evaluating the InBody Band 3 fitness tracker to improve health outcomes and quality of life in Black prostate can…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
This Clinical Trial Update notes that the study evaluating the effect of androgen deprivation therapy on cardiovascular function in prostate…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis
A completed clinical trial from Shanghai Changzheng Hospital evaluating multimodal artificial intelligence systems for diagnosing and progno…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults [Phase 1]
Phase 1 study evaluating the safety, tolerability, biodistribution, radiation dosimetry, and pharmacokinetics of Flotufolastat F-18 Injectio…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland [Phase 2]
Phase 2 study evaluating whether low-dose apalutamide can modulate PSA levels in men scheduled for prostatectomy for prostate cancer; result…
-
EMA approval · 2025-08-29EMA Authorised: Nubeqa (darolutamide) — Bayer AG
The EMA authorised Nubeqa (darolutamide) for use in castration-resistant prostate cancer, expanding the drug's EU indication for Bayer AG as…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers [Phase 2]
Phase 2 clinical trial comparing time-restricted eating versus nutritional counseling to reduce radiation- or chemoradiation-related side ef…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer [NA]
A completed clinical trial evaluating hypofractionated proton radiation therapy for low- and intermediate-risk prostate cancer has been repo…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: 68Ga-PSMA PET/CT for Ra223 Assessment [NA]
A clinical trial at Chang Gung Memorial Hospital is recruiting to assess 68Ga-PSMA PET/CT imaging for evaluating Radium-223 therapy in metas…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Evaluation of Atherosclerotic Plaques in Abdominal CT Studies
NIH Clinical Center is conducting an active-not-recruiting trial evaluating atherosclerotic plaques in abdominal CT studies, with prostate c…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr [NA]
The document reports a clinical trial evaluating CyberKnife ultra-hypofractionated SBRT for localized prostate cancer, which is currently re…
-
CLINICAL_TRIALS withdrawal · 2025-08-28Clinical Trial Update: Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity
A clinical trial evaluating the assay cut-off for the RadTox diagnostic test to predict GI radiation toxicity in prostate cancer patients ha…
-
CLINICAL_TRIALS other · 2025-08-28Clinical Trial Update: PRostate Cancer Enhanced Diagnosis by Calibration Technology
This clinical trial registry entry indicates that a study on enhanced diagnosis for prostate cancer using calibration technology is not yet …
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy
Clinical trial update reporting immune responses in prostate, lung, melanoma, and breast cancer patients after SBRT, IMRT, or brachytherapy.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery [Phase 2]
A Phase 2 clinical trial update evaluating aspirin and rintatolimod with or without interferon-alpha 2b in patients with prostate cancer und…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II) [NA]
This update covers the TUMORNATOR II trial, evaluating MR-Linac-guided radiotherapy as salvage treatment for intraprostatic prostate cancer …
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial comparing cabazitaxel with or without carboplatin to 177Lu-PSMA-617 in metastatic castration-resistant prostate can…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer [Phase 1, Phase 2]
ClinicalTrials.gov update describes a Phase 1/2 trial of FOR46 in combination with enzalutamide for metastatic castration-resistant prostate…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer [NA]
This clinical trial update describes a study evaluating holmium laser enucleation of the prostate (HoLEP) before radiation therapy in men wi…